Merck’s Vioxx scandal widens: Drug maker knew Vioxx was deadly for years before risk was made public
Links shared publicly online about this topic.
- 1,575total visits
Merck’s Vioxx scandal widens: Drug maker knew Vioxx was deadly for years before risk was made public
View full resource at prisonplanet.com
Tags: Heart, Heart Disease, Heart Attack, Stroke, Thrombotic Event, Drug, Vioxx, Merck & Co.
Most Recently Shared on November 27, 2009 at 12:08 pm By:
Whoa!! Did Merck really kill 60,000 people BEFORE saying Vioxx was suspect?? Why do we allow this? http://bit.ly/8TErLw
The Parkinson's Community: Science and Advocacy Working Together Toward a Cure - YouTube
youtube.com — “In February 2012, the Parkinson's Action Network hosted its inaugural Postdoctoral Investigator Poster Session in Washington, DC, at which 17 researchers pre...” View full resource at youtube.com
Most Recently Shared on May 7, 2012 at 5:59 pm By:
Parkinson'sAction Health Organization
Watch PAN's new video about engaging Parkinson's researchers in advocacy! http://t.co/6ZoYcbfH
Top 10 Pharma CEO Salaries of 2011 - FiercePharma
fiercepharma.com — “Top 10 Pharma CEO Salaries of 2011 - FiercePharma” View full resource at fiercepharma.com
Most Recently Shared on May 1, 2012 at 3:13 pm By:
John Carroll Health Communicator
Top 10 Pharma CEO Salaries of 2011 - #pharma http://t.co/V6fUiUPu
AIDSmeds - Top Stories : FDA to Docs: Best to Avoid Victrelis With Norvir-Boosted HIV Protease Inhibitors - by Tim Horn
aidsmeds.com — “Victrelis (boceprevir), Merck?s hepatitis C virus (HCV) protease inhibitor, should not be combined with the following Norvir (ritonavir)-boosted HIV protease inhibitors: Reyataz (atazanavir), Prezista (darunavir) or Kaletra.” View full resource at aidsmeds.com
Most Recently Shared on April 30, 2012 at 1:13 pm By:
Top Stories - FDA to Docs: Best to Avoid Victrelis With Norvir-Boosted #HIV Protease Inhibitors http://t.co/VttAd4rH #hepatitis #HepC #AIDS
POZ - Treatment News : FDA to Docs: Best to Avoid Victrelis With Norvir-Boosted HIV Protease Inhibitors - by Tim Horn
poz.com — “Victrelis (boceprevir), Merck?s hepatitis C virus (HCV) protease inhibitor, should not be combined with the following Norvir (ritonavir)-boosted HIV protease inhibitors: Reyataz (atazanavir), Prezista (darunavir) or Kaletra.” View full resource at poz.com
Most Recently Shared on April 28, 2012 at 2:40 am By:
Health Literacy Medical School
Contentment Linked to Balanced View of One's Past, Present & Future - Not over valuing 1 > another http://t.co/LGB4FOTP @sciencedaily
The IN VIVO Blog: Merck Says Goodbye to Independent Biosimilars Unit
invivoblog.blogspot.com — “The IN VIVO Blog: Merck Says Goodbye to Independent Biosimilars Unit” View full resource at invivoblog.blogspot.com
Most Recently Shared on April 26, 2012 at 9:47 pm By:
Chris Morrison Health Communicator
IVB: Merck's biosimilars chief Mike Kamarck has left the company and the business is now part of MRL's biologics group: http://t.co/ATA65Kfk
Merck ordered to pay $321 million in criminal Vioxx probe | Reuters
in.reuters.com — “(Reuters) - A Boston federal judge on Thursday sentenced Merck & Co to pay a $321 million criminal fine for improperly marketing its Vioxx painkiller a decade ago.The U.S. drugmaker pleaded guilty in” View full resource at in.reuters.com
Most Recently Shared on April 19, 2012 at 8:53 pm By:
Merck ordered to pay $321 million in criminal Vioxx probe http://t.co/g1VMTKG5
Modern Healthcare: Vioxx costs Merck another $322 million
home.modernhealthcare.com — “Modern Healthcare: Vioxx costs Merck another $322 million” View full resource at home.modernhealthcare.com
Most Recently Shared on April 19, 2012 at 7:33 pm By:
Modern Healthcare: Vioxx costs Merck another $322 million http://t.co/7jmVplHa
Merck does cancer drug deal with Endocyte | InPharm
inpharm.com — “InPharm.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, jobs, events, and service company listings.” View full resource at inpharm.com
Most Recently Shared on April 17, 2012 at 2:50 pm By:
Pharmafocus Health News and Pharma
Merck does cancer drug deal with Endocyte - http://t.co/t8XFn4IT
Endocyte could get $1B from Merck development deal - BusinessWeek
businessweek.com — “Endocyte Inc. said Monday that Merck & Co. will help develop and market its experimental cancer drug vintafolide, and Endocyte could get more than $1 billion if the drug is successfully developed as a treatment for multiple types of cancer.” View full resource at businessweek.com
Most Recently Shared on April 16, 2012 at 8:46 pm By:
Dr. P. D Tapp Doctor, Health Executive, and PhD
Merck to buy Endocyte cancer therapy for as much as $1B if tests are successful. http://t.co/cG7H3qTw
Merck signs deal with venture capitalists | InPharm
inpharm.com — “InPharm.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, jobs, events, and service company listings.” View full resource at inpharm.com
Most Recently Shared on April 16, 2012 at 12:00 pm By:
Dr. Aaron Rogers Doctor, Surgeon, ENT Doctor, Physician, and Active Health Library
Merck signs deal with venture capitalists - InPharm http://t.co/9Ui1obrJ
Merck baldness drugs destroy sperm, cause infertility and ejaculation disorders, even after you stop using them
naturalnews.com — “Merck baldness drugs destroy sperm, cause infertility and ejaculation disorders, even after you stop using them” View full resource at naturalnews.com
Most Recently Shared on April 14, 2012 at 4:13 pm By:
Merck baldness drugs destroy sperm, cause infertility and ejaculation disorders http://t.co/NlqGZzjH via @HealthRanger
More Hair, Less Reason for It (MRK)
fool.com — “The Motley Fool - Merck's baldness treatment Propecia has sexual side effects.” View full resource at fool.com
Most Recently Shared on April 14, 2012 at 1:19 am By:
More Hair, Less Reason for It: Merck's baldness treatment Propecia has sexual side effects. http://t.co/SAjAC7a8
Merck Takes Another Shot at Promoting Shingles Vaccine - WSJ.com
online.wsj.com — “Merck officials are cautiously hopeful that the shingles vaccine Zostavax will finally live up to its market potential after several years of manufacturing problems that limited the shot's supply.” View full resource at online.wsj.com
Most Recently Shared on April 13, 2012 at 9:25 pm By:
Merck Takes Another Shot at Promoting Shingles Vaccine http://t.co/JXQZJWch
Living With Diabetes: 'American Idol's' Randy Jackson - Diabetes Center - Everyday Health
everydayhealth.com — “Grammy-award winner producer Randy Jackson is opening up about how a type 2 diabetes changed life as part of a new campaign with Merck.” View full resource at everydayhealth.com
Most Recently Shared on April 13, 2012 at 1:09 pm By:
Living with type 2 #diabetes, American Idol @YO_RANDYJACKSON's story: http://t.co/TsP2zNRn
Study: No benefit for Merck's zoster booster - FierceVaccines
fiercevaccines.com — “Study: No benefit for Merck's zoster booster - FierceVaccines” View full resource at fiercevaccines.com
Most Recently Shared on March 29, 2012 at 4:49 pm By:
Study: No benefit for Merck's zoster booster http://t.co/BCzOy6rG $MRK #pharma #vaccine #failure
Advertisement
